Shares of CASI Pharmaceuticals (NASDAQ:CASI) moved higher by 1.6% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 43.75% year over year to ($0.09), which missed the estimate of ($0.08). read more
Issues in digital infrastructure, information and communications technology (ICT), healthcare and pharmaceuticals, aerospace and defence, entrepreneurship, financial services and investment also came up for discussions at the virtual meeting that saw participation from at least 24 CEOs from both sides.
The analysts covering Inovio Pharmaceuticals, Inc. (NASDAQ:INO) delivered a dose of negativity to shareholders today…
Foreaders 